Exploring the clinicopathological parameters of HER2 low breast cancers: insights from a retrospective cohort study

Purpose Breast cancer subtypes are delineated by human epidermal growth factor receptor 2 (HER2) expression, pivotal in treatment selection. HER2-positive tumors typically respond to targeted therapies, whereas HER2-negative tumors lack HER2 overexpression. However, a subset exhibits low HER2 expres...

Full description

Saved in:
Bibliographic Details
Main Authors: Sana Ahuja, Adil Aziz Khan, Kiruthikasri G, Sufian Zaheer
Format: Article
Language:English
Published: Korean Society of Surgical Oncology 2024-12-01
Series:Korean Journal of Clinical Oncology
Subjects:
Online Access:http://www.kjco.org/upload/kjco-20-2-79.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!